Global Point of Care Diagnostic and Testing Market Size study, by Product Type (Glucose Testing, Hb1ac Testing, Coagulation, Cardiac Markers, Thyroid Stimulating Hormone, Hematology, Primary Care Systems, Blood Gas/Electrolytes, Others), by End-Use (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratory) and Regional Forecasts 2020-2027

  • Product Code:
    RP-ID-10347464
  • Published Date:
    2 Jun 2021
  • Region:
    Global
  • Pages:
    200
  • Category:
    Healthcare & Pharmaceuticals
  • Publisher:
    Pub-ID-14

Impact Analysis on the Growth of Market

Activating Probable Propositions Amidst COVID-19 Crisis

With things going haywire, we analyze key points to make sure that the businesses around the globe are completely prepared to tackle potential implications caused by COVID-19. Be it protecting employees, customers or the overall business operations, we ensure that the employers take the right decisions, make strategic investments and maintain a healthy work culture along with taking probable measures to minimize the financial loss. Know More

Global Point of Care Diagnostic and Testing Market is valued approximately at USD 26.8 billion in 2019 and is anticipated to grow with a healthy growth rate of more than 3.3% over the forecast period 2020-2027. The point of care (POC) diagnostics and testing can be defined as medical devices that are used to obtain an immediate result in the investigation (monitoring and diagnosis) of certain diseases, such as cancer, cardiac diseases, diabetes, hepatitis, and others. Point-of-care testing diagnostics have several advantages over conventional diagnosis methods, as they allow diagnosis of patient at the physician’s office, home, or even in the hospital at a particular time. The results obtained from the diagnostic and testing methods are providing quick treatment facilities to the patient. The rise in prevalence of chronic and infectious diseases, such as cardiac diseases, cancer, respiratory, and others, along with the growing geriatric population are the few factors responsible for the high CAGR of the market during the forecast period. For instance, according to the World Health Organization (WHO), cancer is the second-leading cause of death, followed by the cardiovascular disease, around the world and is accountable for approximately 70% of deaths in the low and middle-income countries in 2018. Similarly, the International Agency for Research on Cancer (IARC) found that around 18.1 million new cancer cases were reported globally in 2018 and the burden of new cases of cancer will reach to almost 27.5 million cases by the year 2040. Likewise, according to the Forum of International Respiratory Societies (FIRS), around 384 million people suffer from chronic obstructive pulmonary disease (COPD) and 3 million die from it each year, thus making it the third leading cause of death worldwide. This, in turn, is likely to strengthen the demand for Point of Care Diagnostic and Testing, thereby contributing to the market growth around the world. Moreover, the rising prominence of POC diagnostics and testing in monitoring of public health also requires the integration of advanced technologies that enable easy networking, which further making it accessible for healthcare professionals to interpret accurate test results. Thus, remote access incorporation of POC diagnosis and tests is expected to fuel up the new avenues for the market in the forthcoming period. However, the high procedure costs, along with lack of adoption of PoC devices in certain emerging countries are the few factors restraining the market growth over the forecast period of 2020-2027.

The regional analysis of the global Point of Care Diagnostic and Testing market is considered for the key regions such as Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the leading/significant region across the world in terms of market share owing to the rising government support to improve patient-centric care approach, along with the presence of large number of market vendors in the region. Whereas Asia-Pacific is anticipated to exhibit the highest growth rate / CAGR over the forecast period 2020-2027. Factors such as the rise in prevalence of chronic and infectious diseases coupled with improving healthcare infrastructure in the developing nations, such as China and India, are the few factors creating a lucrative opportunity for the growth of the Point of Care Diagnostic and Testing market in the Asia-Pacific region.

Major market player included in this report are:
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Danaher Corporation
Becton Dickinson (BD)
Biomerieux SA
Abbott Laboratories
Siemens Healthcare AG
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Product Type:
Glucose Testing
Hb1ac Testing
Coagulation
Cardiac Markers
Thyroid Stimulating Hormone
Hematology
Primary Care Systems
Blood Gas/Electrolytes
Others

By End-Use:
Hospitals
Clinics
Home
Assisted Living Healthcare Facilities
Laboratory

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE

Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2017, 2018
Base year – 2019
Forecast period – 2020 to 2027

Target Audience of the Global Point of Care Diagnostic and Testing Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2018-2027 (USD Billion)
1.2.1. Point of Care Diagnostic and Testing Market, by Region, 2018-2027 (USD Billion)
1.2.2. Point of Care Diagnostic and Testing Market, by Product Type, 2018-2027 (USD Billion)
1.2.3. Point of Care Diagnostic and Testing Market, by End-Use, 2018-2027 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Point of Care Diagnostic and Testing Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Point of Care Diagnostic and Testing Market Dynamics
3.1. Point of Care Diagnostic and Testing Market Impact Analysis (2018-2027)
3.1.1. Market Drivers
3.1.2. Market Challenges
3.1.3. Market Opportunities
Chapter 4. Global Point of Care Diagnostic and Testing Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model (2017-2027)
4.2. PEST Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.3. Investment Adoption Model
4.4. Analyst Recommendation & Conclusion
Chapter 5. Global Point of Care Diagnostic and Testing Market, by Product Type
5.1. Market Snapshot
5.2. Global Point of Care Diagnostic and Testing Market by Product Type, Performance - Potential Analysis
5.3. Global Point of Care Diagnostic and Testing Market Estimates & Forecasts by Product Type 2017-2027 (USD Billion)
5.4. Point of Care Diagnostic and Testing Market, Sub Segment Analysis
5.4.1. Glucose Testing
5.4.2. Hb1ac Testing
5.4.3. Coagulation
5.4.4. Cardiac Markers
5.4.5. Thyroid Stimulating Hormone
5.4.6. Hematology
5.4.7. Primary Care Systems
5.4.8. Blood Gas/Electrolytes
5.4.9. Others
Chapter 6. Global Point of Care Diagnostic and Testing Market, by End-Use
6.1. Market Snapshot
6.2. Global Point of Care Diagnostic and Testing Market by End-Use, Performance - Potential Analysis
6.3. Global Point of Care Diagnostic and Testing Market Estimates & Forecasts by End-Use 2017-2027 (USD Billion)
6.4. Point of Care Diagnostic and Testing Market, Sub Segment Analysis
6.4.1. Hospitals
6.4.2. Clinics
6.4.3. Home
6.4.4. Assisted Living Healthcare Facilities
6.4.5. Laboratory
Chapter 7. Global Point of Care Diagnostic and Testing Market, Regional Analysis
7.1. Point of Care Diagnostic and Testing Market, Regional Market Snapshot
7.2. North America Point of Care Diagnostic and Testing Market
7.2.1. U.S. Point of Care Diagnostic and Testing Market
7.2.1.1. Product Type breakdown estimates & forecasts, 2017-2027
7.2.1.2. End-Use breakdown estimates & forecasts, 2017-2027
7.2.2. Canada Point of Care Diagnostic and Testing Market
7.3. Europe Point of Care Diagnostic and Testing Market Snapshot
7.3.1. U.K. Point of Care Diagnostic and Testing Market
7.3.2. Germany Point of Care Diagnostic and Testing Market
7.3.3. France Point of Care Diagnostic and Testing Market
7.3.4. Spain Point of Care Diagnostic and Testing Market
7.3.5. Italy Point of Care Diagnostic and Testing Market
7.3.6. Rest of Europe Point of Care Diagnostic and Testing Market
7.4. Asia-Pacific Point of Care Diagnostic and Testing Market Snapshot
7.4.1. China Point of Care Diagnostic and Testing Market
7.4.2. India Point of Care Diagnostic and Testing Market
7.4.3. Japan Point of Care Diagnostic and Testing Market
7.4.4. Australia Point of Care Diagnostic and Testing Market
7.4.5. South Korea Point of Care Diagnostic and Testing Market
7.4.6. Rest of Asia Pacific Point of Care Diagnostic and Testing Market
7.5. Latin America Point of Care Diagnostic and Testing Market Snapshot
7.5.1. Brazil Point of Care Diagnostic and Testing Market
7.5.2. Mexico Point of Care Diagnostic and Testing Market
7.6. Rest of The World Point of Care Diagnostic and Testing Market
Chapter 8. Competitive Intelligence
8.1. Top Market Strategies
8.2. Company Profiles
8.2.1. F. Hoffmann-La Roche Ltd.
8.2.1.1. Key Information
8.2.1.2. Overview
8.2.1.3. Financial (Subject to Data Availability)
8.2.1.4. Product Summary
8.2.1.5. Recent Developments
8.2.2. Qiagen N.V.
8.2.3. Danaher Corporation
8.2.4. Becton Dickinson (BD)
8.2.5. Biomerieux SA
8.2.6. Abbott Laboratories
8.2.7. Siemens Healthcare AG
8.2.8. Zoetis, Inc.
8.2.9. Instrumentation Laboratory
8.2.10. Nova Biomedical
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes
9.3. Research Assumption
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report
F. Hoffmann-La Roche Ltd.
Qiagen N.V.
Danaher Corporation
Becton Dickinson (BD)
Biomerieux SA
Abbott Laboratories
Siemens Healthcare AG
Zoetis, Inc.
Instrumentation Laboratory
Nova Biomedical
Please enter your personal details below
*
I want to buy this report
I am willing to know the scope of research
I have customized query over this report

Related Reports